Management of central serous chorioretinopathy: Expert panel discussion

被引：5

作者：

Chhablani, Jay ^{[1
]}

Anantharaman, Giridhar ^{[2
]}

Behar-Cohen, Francine ^{[3
,4
,5
,6
]}

Boon, Camiel ^{[7
,8
]}

Manayath, George ^{[9
]}

Singh, Rishi ^{[10
]}

机构：

[1] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreoretinal Dis, Banjara Hills, Hyderabad 500034, Telangana, India

[2] Giridhar Eye Inst, Dept Vitreoretinal Serv, Cochin, Kerala, India

[3] Univ Lausanne, Dept Ophthalmol, Jules Gonin Eye Hosp, Fdn Asile des Aveugles, Lausanne, Switzerland

[4] UPMC Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, Team 1 & 17, Paris, France

[5] Ctr Rech Cordeliers, INSERM, Paris, France

[6] Univ Paris 05, Sorbonne Paris Cite, Ctr Rech Cordeliers, Paris, France

[7] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands

[8] Univ Amsterdam, Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands

[9] Aravind Eye Hosp, Dept Retina & Ocular Oncol, Coimbatore, Tamil Nadu, India

[10] Cole Eye Inst, Cleveland, OH USA

来源：

INDIAN JOURNAL OF OPHTHALMOLOGY | 2018年 / 66卷 / 12期

关键词：

Central serous chorioretinopathy; management; choroid; retina; expert panel;

D O I：

10.4103/ijo.IJO_1411_18

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Central serous chorioretinopathy (CSCR), one of the most common diseases in retina clinics, needs a special attention by retina specialists. Considering the challenges in diagnosis, classification, and management of this enigmatic disease and lack of level 1 evidence, there is a need for consensus with regard to establishing management protocols.

引用

页码：1700 / 1703

页数：4

共 50 条

[31] Corticosteroids and central serous chorioretinopathy
Carvalho-Recchia, CA
Yannuzzi, LA
Negrao, S
Spaide, RF
Freund, KB
Rodriguez-Coleman, H
Lenharo, M
Iida, T
OPHTHALMOLOGY, 2002, 109 (10) : 1834 - 1837
[32] Brachytherapy for Central Serous Chorioretinopathy
Arora, Supriya
Stea, Baldassarre D.
Hamilton, Russell J.
Chhablani, Jay
OPHTHALMOLOGY AND THERAPY, 2022, 11 (05) : 1611 - 1616
[33] The Legend of Central Serous Chorioretinopathy
Yannuzzi, Lawrence A.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
[34] Biomarkers for central serous chorioretinopathy
Nkrumah, Gideon
Paez-Escamilla, Manuel
Singh, Sumit Randhir
Rasheed, Mohammed Abdul
Maltsev, Dmitri
Guduru, Abhilash
Chhablani, Jay
THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2020, 12
[35] Occult Central Serous Chorioretinopathy
Freund, K. Bailey
Warrow, David
Gallego-Pinazo, Roberto
Quan Hoang
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[36] CENTRAL SEROUS CHORIORETINOPATHY IN WOMEN
Musetti, Donatella
Nicolo, Massimo
Traverso, Carlo
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[37] Traumatic central serous chorioretinopathy
Ramchandani, Suresh
Paritekar, Prajakta
Shah, Prachi
Sharma, Sumedha
INDIAN JOURNAL OF OPHTHALMOLOGY, 2015, 63 (11)
[38] Central serous chorioretinopathy: Treatment
Park, Jong
Kim, Kiyoung
Kang, Min
Kim, Eung
Yu, Seung-Young
TAIWAN JOURNAL OF OPHTHALMOLOGY, 2022, 12 (04) : 394 - 408
[39] Masqueraders of central serous chorioretinopathy
Sahoo, Niroj Kumar
Singh, Sumit Randhir
Rajendran, Anand
Shukla, Dhananjay
Chhablani, Jay
SURVEY OF OPHTHALMOLOGY, 2019, 64 (01) : 30 - 44
[40] Central serous chorioretinopathy and glucocorticoids
Cusani, M
SURVEY OF OPHTHALMOLOGY, 2004, 49 (01) : 128 - 129

← 1 2 3 4 5 →